San Diego genetic sequencing pioneer Illumina was fined a record $476 million by the European Union on Wednesday for closing its takeover of cancer test maker Grail before securing antitrust approval.
San Diego genetic sequencing pioneer Illumina was fined a record $476 million by the European Union on Wednesday for closing its takeover of cancer test maker Grail before securing antitrust approval.
